ArticleFrontiers in cardiovascular medicine2026
Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methods: A total of 618 STEMI patients who underwent PCI were retrospectively enrolled. The primary endpoint was 1-year MACE. Feature selection was performed using the Boruta algorithm. Multivariable Cox regression analysis was conducted to evaluate the independent association between CTI and MACE. The incremental prognostic information provided by CTI was assessed using 365-day time-dependent receiver operating characteristic (ROC) curves and the DeLong test, while clinical utility was evaluated using decision curve analysis (DCA). Subgroup analysis was performed according to diabetes status. Sensitivity analyses using different adjustment strategies were conducted to assess the robustness of the results. Results: During follow-up, 139 patients (22.5%) experienced MACE. CTI was identified as an important predictor by the Boruta algorithm and remained independently associated with MACE in multivariable Cox regression analysis (HR = 1.443, 95% CI: 1.191-1.748, Conclusions: CTI was an independent predictor of MACE in STEMI patients undergoing PCI. Notably, the association appeared to be mainly driven by acute heart failure events, suggesting a close relationship between CTI and post-infarction ventricular dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.